Figure 3 from Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit

Key Points

• Kaplan–Meier curves illustrate overall survival rates for patients receiving PPIs in colorectal cancer.
• Patients in the immunotherapy trials demonstrated varying outcomes depending on the drug interactions present.
• The analysis highlights the significance of understanding drug interactions within solid tumor immunotherapy.
• These findings may guide future treatment strategies by assessing drug interaction impacts on patient outcomes.